We're excited to announce our participation in the oversubscribed $18.7M Series A financing for ChEmpower, a company that's pioneering a revolutionary approach to semiconductor manufacturing.

As demand for electric vehicles (EVs), portable electronics, and grid-scale energy storage grows, limitations of traditional lithium-ion batteries (LIBs) have begun to surface. In Part 1 of our two-part look at next-generation battery materials, we explore the forces influencing innovation in the category.

Kanvas Biosciences, a Pangaea Ventures portfolio company, has published new research on its High-Phylogenetic-Resolution Spatial Mapping (HiPR-Map) Platform spectral imaging technology. This novel tool promises to transform how researchers visualize and analyze the complexities of the microbiome.

Calysta and Marsapet have launched the first complete dog food featuring FeedKind Pet protein, a cultured protein fermented without using any arable land or animal ingredients.

ESS Tech, Inc. announced that the company’s global fleet of LDES solutions has transacted nearly 2.5 GWh of transacted energy

Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140M Series B financing round.

As we explored in Part 1, the semiconductor industry faces unprecedented challenges in meeting AI's computational demands. From novel manufacturing approaches to revolutionary thermal management solutions, explore how the industry is adapting to power the next generation of AI computing.

As AI transforms our world, demand for more powerful computing is growing at an unprecedented rate. The GPU (Graphics Processing Unit) market is expected to surge from $44 billion in 2024 to $274 billion by 2029 – a growth trajectory that outpaces nearly every other semiconductor sector.

ESS Tech, Inc. today celebrated the first commercial deliveries of Energy Center™ systems to a major Florida utility and the completion of construction and initial testing of a previously announced demonstration for its partner Portland General Electric (PGE).

We are excited to announce  Aspect Biosystems has secured US$115 million Series B financing led by Dimension to advance their groundbreaking work in bioprinted tissue therapeutics. 

As we conclude 2024, we reflect on a transformative year in hard tech innovation.

Carbon removal technologies are often seen as costly necessities rather than profitable ventures. But a new paradigm is shifting this perspective, showcasing how carbon capture solutions can deliver immediate value while safeguarding the planet's future.

The multi-party collaboration will enable embodied carbon reductions at NEOM's large scale construction projects.

Green hydrogen could deliver 10% of required emissions reductions needed to reach net-zero by 2050, particularly in hard-to-decarbonize sectors like heavy industry and long-haul transport.

The tasty mocha, a centuries-old beverage combining coffee, cocoa, sugar, and dairy, stands at the intersection of some of the most active areas in food technology innovation.

Our decision to lead the Series C funding round for Green Theme Technologies' (GTT), a company making textile production more sustainable, underscores our commitment to breakthrough technologies that enable better, more sustainable outcomes for industry and the environment

Kanvas Biosciences, a full-stack spatial biology company, announced data from a clinical trial that produced results that de-risk the development of Kanvas Bio’s lead immuno-oncology drug.

As global challenges demand bold and innovative solutions, deep science, advanced materials, biosciences, and more are emerging as the necessary tools to tackle these problems.

Through its proprietary bioprinting technology, Aspect Biosystems creates functional human tissues with unprecedented precision and control. These 3D-printed tissues can restore a diseased state without the constraints of traditional organ transplantation.